Biosimilar infliximab in real-life Crohn's disease's anti-TNFalfa naive patients: a comparative observational cohort study (SIMRECRO study)

被引：0
|
作者：
Carvalho Lourenco, L. [1 ]
Anapaz, V. [1 ]
Oliveira, A. M. [1 ]
Branco, J. [1 ]
Cardoso, M. [1 ]
Graca Rodrigues, C. [1 ]
Santos, L. [1 ]
Horta, D. [1 ]
Martins, A. [1 ]
Reis, J. [1 ]
机构：
[1] Hosp Prof Dr Fernando Fonseca, Serv Gastrenterol, Amadora, Portugal
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P327
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 50 条
  • [31] Effectiveness and safety of reference infliximab and biosimilar in Crohn's disease: a French equivalence study
    Meyer, A.
    Rudant, J.
    Drouin, J.
    Weill, A.
    Carbonnel, F.
    Coste, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S49 - S49
  • [32] Predictors of Sustained Response to Infliximab in Patients With Crohn's Disease: A Single Cohort Study
    Duricova, Dana
    Malickova, Karin
    Bortlik, Martin
    Machkova, Nadezda
    Komarek, Viktor
    Bouzkova, Eva
    Lukas, Milan
    GASTROENTEROLOGY, 2011, 140 (05) : S593 - S593
  • [33] USE OF ADALIMUMAB BIOSIMILAR ABP 501 IN CROHN'S DISEASE: AN OBSERVATIONAL STUDY
    Ribaldone, D. G.
    Vernero, M.
    Pellicano, R.
    Morino, M.
    Saracco, G. M.
    Astegiano, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S118 - S118
  • [34] Evaluation of the effectiveness of vedolizumab in patients with Crohn's disease: a multicenter real-life study from Argentina
    Balderramo, D. C.
    Etchevers, J.
    Fuxman, C.
    Lubrano, P.
    Bellicoso, M.
    Correa, G.
    Trakal, J.
    Defago, M. R.
    Montero, J.
    Toro, M.
    Novillo, A.
    Bonardo, M.
    Arancibia, N.
    Motanez, S.
    Quines, S.
    Huernos, S.
    Gil, A.
    Gonzalez, R.
    Goncalves, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1316 - I1316
  • [35] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mazzuoli, S.
    Manguso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Minerba, L.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
  • [36] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mazzuoli, S.
    Manguso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Minerba, L.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
  • [37] COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN'S DISEASE PATIENTS FAILURE TO TNF INHIBITORS
    Onali, S.
    Pugliese, D.
    Caprioli, F. A.
    Orlando, A.
    Biancone, L.
    Nardone, O. M.
    Imperatore, N.
    Fiorino, G.
    Cappello, M.
    Viola, A.
    Principi, M. B.
    Bezzio, C.
    Aratari, A.
    Carparelli, S.
    Mancuso, F.
    Grossi, L.
    Bodini, G.
    Ribaldone, D.
    Mocci, G.
    Favale, A.
    Grova, M.
    Scucchi, L.
    Segato, S.
    Fries, W.
    Castiglione, F.
    Armuzzi, A.
    Fantini, M. C.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S140 - S141
  • [38] Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
    Benucci, Maurizio
    Li Gobbi, Francesca
    Bandinelli, Francesca
    Damiani, Arianna
    Infantino, Maria
    Grossi, Valentina
    Manfredi, Mariangela
    Parisi, Simone
    Fusaro, Enrico
    Batticciotto, Alberto
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Meacci, Francesca
    IMMUNOLOGIC RESEARCH, 2017, 65 (01) : 419 - 422
  • [39] Safety, efficacy and immunogenicity of switching from innovator to biosimilar infliximab in patients with spondyloarthritis: a 6-month real-life observational study
    Maurizio Benucci
    Francesca Li Gobbi
    Francesca Bandinelli
    Arianna Damiani
    Maria Infantino
    Valentina Grossi
    Mariangela Manfredi
    Simone Parisi
    Enrico Fusaro
    Alberto Batticciotto
    Piercarlo Sarzi-Puttini
    Fabiola Atzeni
    Francesca Meacci
    Immunologic Research, 2017, 65 : 419 - 422
  • [40] Ustekinumab is an effective and safe therapy in anti-TNF refractory Crohn's Disease: a two year real-life observational study from Spain
    Rueda Sanchez, J.
    Cabello Ramirez, N.
    Camara Baena, S.
    Keco Huerga, A.
    de la Borbolla Serres, J. Garcia
    Castro Fernandez, M.
    Grande Santamaria, L.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S352 - S352
12345